The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back

Cancer Immunology Immunotherapy

Volumn 45, Issue 5, 1997, Pages 241-249

  Berghella, Anna Maria ^a   Pellegrini, Patrizia ^a   Del Beato, Tiziana ^a   Marini, Matteo ^a   Tomei, Ennio ^a   Adorno, Domenico ^a   Casciani, Carlo Umberto ^a  

^a Istituto Tipizzazione Tissutale L'Aquila   (Italy)

Author keywords

Colorectal cancer; Cytokine network; sIL 2R; TH1; TH2

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CYTOKINE; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR;

ANTIBODY RESPONSE; ARTICLE; CELL DIFFERENTIATION; CELL POLARITY; COLORECTAL CANCER; GENE SWITCHING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STEM CELL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; REGRESSION ANALYSIS; SOLUBILITY; TH1 CELLS; TH2 CELLS;

EID: 0031449204     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050439     Document Type: Article

References (39)

1. Banchereau J (1995) Converging and diverging properties of human interleukin-4 and interleukin-10. Behring Inst Mitt 96:58
2. + precursor subpopulations J Immunol 149:2489
3. + precursor subpopulations. J Immunol 151:2895
4. Berghella AM, Pellegrini P, Piancatelli D, Maccarone D, Del Beato T, Giubilei D, Pomidori A, Adorno D, Casciani CU (1994) Progression mechanisms in colon cancer: sIL-2R, IL-2+anti-CD3 proliferative response and tumour stage correlations. Cancer Immunol Immunother 38:160
5. Berghella AM, Pellegrini P, Del Beato T, Maccarone D, Adorno D, Casciani CU (1996) Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm 11:355
6. Bloom BR, Salgame P, Diamond B (1992) Revisiting and revising suppressor T cells. Immunol Today 13:131
7. Bodey B, Psenko V, Lipsey AL, Kaiser HE (1996) Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms. Anticancer Res 16:219
8. Bowker DW, Bridge PD, Dunstan FDJ, Fry JC, Iles TC, Randerson PF, Wiegert RG (1993) Biological data analysis. In: Fry JC (ed) A practical approach. Oxford University Press, New York
9. Bradley LM, Yoshimoto K, Swain SL (1995) The cytokines IL-4, IFN-gamma, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro. J Immunol 155:1713
10. Chen L, Tourvielle B, Burns GF, Bach FH, Mathieu-Mahul D, Sasportes M, and Bensussan A (1986) Interferon: a cytotoxic T lymphocyte differentiation signal. Eur J Immunol 16:767
11. Cher DJ, Mosmann TR (1987) Two types of murine helper T cell clones. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138:3688
12. + T-cell subsets in vivo. Immunol Rev 123:189
13. Contasta I, Pellegrini P, Berghella AM, Del Beato T, Canossi A, Di Rocco M, Adorno D, Casciani CU (1996) Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer. Cancer Biother Radiopharm 11:373
14. Dummen R, Posseckert G, Sugamura K, Grundmann H, Burg G (1996) Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains. J Interferon Cytokine Res 16:315
15. Erard F, Wild MT, Garcia-Sanz JA, LE Gros G (1993) Switch of CD8 T cells to noncytolytic CD8-CD4-cells that make TH2 cytokines and help B cells. Science 260:1802
16. Fossa SD, Aamdal S, Naume B, Gallati H (1995) Serum levels of cytokines and soluble cytokines receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2 interferon-alpha combination therapy. Acta Oncol 34:599
17. Gillis S, Gillis AE, Henney CS (1981) Monoclonal antibody directed against IL-2: inhibition of T lymphocyte mitogenesis and in vitro differentiation of alloreactive cytotoxic T cells. J Exp Med 154:983
18. Hart PH, Jones CA, Finlay Jones JJ (1995) Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J Leukoc Biol 57:909
19. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Köhler G (1993) Disruption of the murine IL-4 gene blocks TH2 cytokine responses. Nature 362:245
20. Lopez M, Dilauro L, Paoletti G, Santini S, Grandolfo GM, Vitelli G, Sfrasca AM, Ameglio F, Rasi G, Garaci E (1995) Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2-clinical and immunological effects. Ann Oncol 6:1011
21. Maraskovsky E, Chen WF, Shortman K (1989) IL-2 and IFNγ are two necessary lymphokines in the development of cytolytic T cells. J Immunol 143:1210
22. + T cells. Immunol Rev 123:209
23. Mulé JJ, Custer MC, Travis WD, Rosenberg SA (1992) Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice. J Immunol 148:2622
24. Murray JS, Madri J, Pasqualini T, Bottomly K (1993) Functional CD4 Tcell subset interplay in an intact immune system. J Immunol 150:4270
25. Ogata K, Yokose N, An E, Kamikubo K, Tamura H, Dan K, Sakamaki H, Onozawa Y, Hamaguchi H, Nomura T (1996) Plasma soluble interleukin-2 receptor level in patients with primary myelodysplastic syndromes - a relationship with disease subtype and clinical outcome. Br J Haematol 93:45
26. + T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother 42:1
27. Pellegrini P, Berghella AM, Del Beato T, Maccarone D, Adorno D, Casciani CU (1996) Immunological directives for biotherapy improvement in the treatment of colorectal cancer. Cancer Biother Radiopharm 11:113
28. + T cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases. Immunol Rev 123:23
29. + human T lymphocyte subsets. Eur J Immunol 23:61
30. Rubin LA, Kurman CC, Fritz ME (1986) Identification and characterization of a released form of the interleukin-2 receptor. In: Leukocytes and host defense, Liss, New York, p 95
31. Stevens TL, Bossie A, Sanders WM, Fernandez-Botram R, Coffman LR, Mosmann RT, Vitetta ES (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255
32. Street NE, Schumacher JH, Fong TA, Boss H, Fiorentino DF, Leveran JA, Musmann TR (1990) Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting diluition cloning for precursors of TH1 and TH2 cells. J Immunol 144:1629
33. Tanaka T, Hu-Li J, Seder RA, Fazekas de St Groth B, Paul WE (1993) Interleukin 4 suppresses interleukin 2 and interferon γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA 90:5914
34. Thomson AW, Dinarello CA, Goldsmith MA, Greene WC, Bancherau J, Rybak ME, Hirano T, Mosman TR, De Maeyer E, De Maeyer-Guignard J, Tracey KS, Pugh-Humphreys RGP (1994) In: Thomson A (ed) The cytokine handbook. Academic Press, San Diego, Calif
35. Treiberheld S, Stewart DM, Barraclough HA, Kurman CC, Nelson DL (1996) Release of sIL-2R-alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15. Clin Immunol Immunopathol 80:67
36. Wagner H, Hardt C, Rouse BT, Roellinghoff M, Scheurich P, Pfizenmaier K (1982) Dissection of the proliferative and differentiation signals controlling murine cytotoxic T lymphocyte responses. J Exp Med 155:1876
37. Wasik MA, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polansky M, Kadin ME (1996) Increased serum concentration of the soluble inlerleukin-2 receptor in cutaneous T-cell lymphoma-clinical and prognostic implications. Arch Dermatol 132:42
38. Williams ME, Lichtman AH, Abbas KA (1990) Anti-CD3 antibody induces unresponsiveness to IL-2 in TH1 clones but non in TH2 clones. J Immunol 144:1208
39. + cytotoxic T lymphocytes. J Immunol 143:1518